ArticleScientific reports2019
Toll-like receptor 3 as a new marker to detect high risk early stage Non-Small-Cell Lung Cancer patients.
Francesca Bianchi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it